Nose Sinuses

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC8-20

DiraChart Clinical Reference
Protected section 20 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 20 of 25PreviousNext

16. Weak vs. strong documentation

Paired entries for this system. The left column is denial-bait; the right column is the same clinical picture written so a reviewer can see why a nurse was required.

Weak — does not survive

Why it fails

Strong — defensible

“Nose okay.”

No patency, bleeding, or cannula-skin assessment — a layperson observation.

“Nares patent bilaterally; no epistaxis; cannula skin intact at nares/columella/ears at 2 L/min; unchanged from baseline.”

“On oxygen.”

Records a fact, not cannula-skin surveillance.

“Continuous O2 at 2 L/min; skin under cannula and behind ears intact without pressure marks; padding in place; skin-care reinforced.”

“Had a nosebleed.”

No volume, no control, no anticoagulation context.

“Anterior epistaxis, moderate, controlled after 10 min firm pressure; on apixaban, BP 150/88; prevention taught; threshold to call reviewed.”

“Nose bleeding.”

No response to pressure, no escalation.

“Epistaxis not controlled after 15 min pressure, moderate volume, on apixaban, SBP 182; EMS activated; MD notified (see Anticoagulation/HTN).”

“Educated on oxygen.”

No content, no learner response.

“Cannula skin care and epistaxis control taught; caregiver return-demonstrated pressure technique and skin checks; verbalized when to call 911.”

“Skin under nose red.”

No offloading, no notification, no plan.

“Early erythema of nares under cannula, non-blanching; offloaded with padding, tubing repositioned; MD notified; reassess next visit (see Wounds).”

Section NavigationPart 20 of 25PreviousNext